A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Infectious disease epidemics have become more frequent and more complex during the 21st century, posing a health threat to the general public and leading to psychological symptoms. The current study was designed to investigate the prevalence of and risk factors associated with depression, anxiety and insomnia symptoms during epidemic outbreaks, including COVID-19. We systematically searched the PubMed, Embase, Web of Science, OVID, Medline, Cochrane databases, bioRxiv and medRxiv to identify studies that reported the prevalence of depression, anxiety or insomnia during infectious disease epidemics, up to August 14th, 2020. Prevalence of mental symptoms among different populations including the general public, health workers, university students, older adults, infected patients, survivors of infection, and pregnant women across all types of epidemics was pooled. In addition, prevalence of mental symptoms during COVID-19 was estimated by time using meta-regression analysis. A total of 17,506 papers were initially retrieved, and a final of 283 studies met the inclusion criteria, representing a total of 948,882 individuals. The pooled prevalence of depression ranged from 23.1%, 95% confidential intervals (95% CI: [13.9–32.2]) in survivors to 43.3% (95% CI: [27.1–59.6]) in university students, the pooled prevalence of anxiety ranged from 25.0% (95% CI: [12.0–38.0]) in older adults to 43.3% (95% CI: [23.3–63.3]) in pregnant women, and insomnia symptoms ranged from 29.7% (95% CI: [24.4–34.9]) in the general public to 58.4% (95% CI: [28.1–88.6]) in university students. Prevalence of moderate-to-severe mental symptoms was lower but had substantial variation across different populations. The prevalence of mental problems increased over time during the COVID-19 pandemic among the general public, health workers and university students, and decreased among infected patients. Factors associated with increased prevalence for all three mental health symptoms included female sex, and having physical disorders, psychiatric disorders, COVID infection, colleagues or family members infected, experience of frontline work, close contact with infected patients, high exposure risk, quarantine experience and high concern about epidemics. Frequent exercise and good social support were associated with lower risk for these three mental symptoms. In conclusion, mental symptoms are common during epidemics with substantial variation across populations. The population-specific psychological crisis management are needed to decrease the burden of psychological problem and improve the mental wellbeing during epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Psychological Impact of Quarantine and How to Reduce It: Rapid Review of the Evidence
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020) · doi:10.2139/ssrn.3532534 · Cited by 16,394
The psychological impact of quarantine and how to reduce it: Rapid review of the evidence
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30460-8 · Cited by 16,378
Pappa, S., Ntella, V., Giannakas, T., Giannakoulis, V. G., Papoutsi, E., & Katsaounou, P. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.026 · Cited by 3,617 · cited 1×
“Recent published metaanalyses also pointed the existence of high prevalence of mental symptoms during COVID-19 among populations including general public and health workers [12, 13].”
BackgroundPierce, M., Hope, H., Ford, T., Hatch, S., Hotopf, M., John, A., Kontopantelis, E., Webb, R., Wessely, S., McManus, S., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30308-4 · Cited by 2,621
The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus.
Kang, L., Li, Y., Hu, S., Chen, M., Yang, C., Yang, B. X., Wang, Y., Hu, J., Lai, J., Ma, X., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30047-x · Cited by 2,061 · cited 1×
“Accumulating studies have investigated the prevalence of mental health problems during infectious disease epidemics in different populations, typically focusing on the general public [6], healthcare workers [7, 8], university students [9], infected survivors [10], and the pregnant women [11].”
BackgroundSelf-citation2019-nCoV epidemic: Address mental health care to empower society
Bao, Y., Sun, Y., Meng, S., Shi, J., & Lu, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30309-3 · Cited by 2,038
Self-citationOnline mental health services in China during the COVID-19 outbreak
Liu, S., Yang, L., Zhang, C., Xiang, Y.-T., Liu, Z., Hu, S., & Zhang, B. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30077-8 · Cited by 1,992 · cited 1×
“Thus, stratified strategies should be applied to treat different populations during epidemics [18, 31, 32].”
BackgroundSARS control and psychological effects of quarantine, Toronto, Canada
Hawryluck, L., Gold, W. L., Robinson, S., Pogorski, S., Galea, S., & Styra, R. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1007.030703 · Cited by 1,929
Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.037 · Cited by 1,804
Santini, Z. I., Jose, P. E., York Cornwell, E., Koyanagi, A., Nielsen, L., Hinrichsen, C., Meilstrup, C., Madsen, K. R., & Koushede, V. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30230-0 · Cited by 1,755
Cited by
Cheung, D. S. T., Yu, B. Y.-M., Lam, S. C., Leung, D. Y. P., Chung, K.-F., Ho, F. Y.-Y., Chen, S.-C., & Yeung, W.-F. (2024) · Sleep and Biological Rhythms · doi:10.1007/s41105-023-00486-w · Cited by 6
(n.d.) · Progress in Neuro-Psychopharmacology and Biological Psychiatry / PsyPost · doi:10.1016/j.pnpbp.2026.111679
Metadata
- Authors
- Yuan, K., Zheng, Y.-B., Wang, Y.-J., Sun, Y.-K., Gong, Y.-M., Huang, Y.-T., Chen, X., Liu, X.-X., Zhong, Y., Su, S.-Z., Gao, N., Lu, Y.-L., Wang, Z., Liu, W.-J., Que, J.-Y., Yang, Y.-B., Zhang, A.-Y., Jing, M.-N., Yuan, C.-W., Zeng, N., Vitiello, M. V., Patel, V., Fazel, S., Minas, H., Thornicroft, G., Fan, T.-T., Lin, X., Yan, W., Shi, L., Shi, J., Kosten, T., Bao, Y.-P., & Lu, L.
- Venue
- Molecular Psychiatry
- Published
- 2022-06-06
- Volume
- 27
- Issue
- 8
- Pages
- 3214-3222
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W4281648256
- Cited by
- 204
- References
- 27
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. https://app.cochat.ai/papers/10.1038/s41380-022-01638-z
- The paper
- Yuan, K., Zheng, Y.-B., Wang, Y.-J., Sun, Y.-K., Gong, Y.-M., Huang, Y.-T., Chen, X., Liu, X.-X., Zhong, Y., Su, S.-Z., Gao, N., Lu, Y.-L., Wang, Z., Liu, W.-J., Que, J.-Y., Yang, Y.-B., Zhang, A.-Y., Jing, M.-N., Yuan, C.-W., . . . Lu, L. (2022). A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01638-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.